In this respect, PTEN is often disrupted in tumour cells, and this emphasizes the role of the insulin/IGF-I-induced PI3K/Akt/mTOR/S6K signaling in cancer [75] (Figure 3). This evidence concerns the gene AKT1 and neoplasm.